SGLT2 Inhibitors Protect Against Kidney Disease in T2DM
THURSDAY, Oct. 10, 2019 -- A class of diabetes drugs, called sodium-glucose co-transporter-2 (SGLT2) inhibitors, protect against kidney disease in patients with type 2 diabetes, according to a review published online Sept. 5 in The Lancet Diabetes...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | Pharmaceuticals | SGLT2 Inhibitors | Sodium | Urology & Nephrology